Agno Pharma

Agno Pharma is a global pharmaceutical contract research and manufacturing organization (CRO & CMO). Agno Pharma engages in the research, development, manufacturing, sourcing, marketing and distribution of chemically and biologically derived pharmaceutical intermediates, APIs, nutraceuticals, and fine chemicals. Agno Pharma is a fully integrated company with in-house business development, R&D, manufacturing and regulatory compliance capabilities. Agno Pharma is your strategic CRO & CMO for your drug discovery, development, and commercialization. Our company is founded upon our belief in the synergistic merger of ICH pharmaceutical technologies, management, product registration, and cGMP compliance with China’s economical research, development, and manufacturing capabilities. This synergy allows us to provide highest quality services and products to our clients in a timely manner that is extremely cost competitive.Over the last 10 years, we have successfully demonstrated our excellent track record in meeting ICH country client’s expectations. Our clients span from small startup biopharmaceuticals to the world’s largest pharmaceutical companies. Our projects, and products, range from pre-clinical to commercial and to generic, from milligram to hundreds of metric tons. Each member of our experienced US, Europe and Japan business development team has more than 10 years of pharmaceutical industry experience working for multinational pharmaceutical companies prior to joining our management team. All members of our organization are fully committed to quality and compliance to ensure our services and products meeting highest quality standards. Furthermore, our client’s intellectual properties are honored and protected by our honest and dedicated people with highest integrity, in addition to our vigorous IP protection systems.Over the last 10 years, in addition to establishing our wholly-owned manufacturing facility and capabilities, we have developed excellent networks of proven and reliable Chinese manufacturers. This allows us to provide efficient and cost-effective sourcing services to our clients. In addition, we have filed numerous US DMFs (in CTD format) and implemented ICH cGMP compliance systems for many Chinese generic API manufacturers. This allows us to exclusively distribute many quality and cost-effective generic APIs from China to ICH clients. All products provided by our partnering Chinese manufacturers are tested in-house independently to verify product quality prior to shipment. This additional service ensures that our clients are receiving timely and quality products at all times.Agno Pharma is a member of SOCMA and DCAT. We honor and practice ChemStewardˇs core principles to ensure all our services and products are environmentally friendly.